Gustavo Mahler

Gustavo Mahler serves as the Chief Executive Officer at Cellistic and Ncardia since January 2023. Previously, Gustavo held the position of Venture Partner at Dynamk Capital LLC from May 2019 to December 2022 and was an Executive Board Member at Life Science Washington during the same period. Additionally, Gustavo had a significant tenure at AGC Biologics, where roles included Member of the Board of Directors, CEO, and President and Global Chief Operations Officer, overseeing all global operations. Responsibilities also included the management of manufacturing operations for CMC Icos Biologics as President. Board Member contributions were made at AbSci between June 2018 and June 2021. Gustavo's early career at Bayer Healthcare included serving as VP of Technical Operations, managing substantial manufacturing operations for Factor VIII. Educational credentials encompass a PhD and MBA from the University of Buenos Aires, alongside a Leadership and Management certification from MIT Sloan School of Management.